Your browser doesn't support javascript.
loading
The cost-effectiveness of treating childhood cancer in 4 centers across sub-Saharan Africa.
Githang'a, Jessie; Brown, Biobele; Chitsike, Inam; Schroeder, Kristin; Chekwenda-Makore, Nester; Majahasi, Flora; Ogundoyin, Olakayode; Renner, Lorna; Petricca, Kadia; Denburg, Avram E; Horton, Sue E; Gupta, Sumit.
Affiliation
  • Githang'a J; Department of Human Pathology, University of Nairobi, Nairobi, Kenya.
  • Brown B; Department of Paediatrics, College of Medicine, University College Hospital, University of Ibadan, Ibadan, Nigeria.
  • Chitsike I; Department of Paediatrics and Child Health, College of Health Sciences, University of Zimbabwe, Harare, Zimbabwe.
  • Schroeder K; Department of Pediatrics and Global Health, Duke University School of Medicine, Durham, North Carolina.
  • Chekwenda-Makore N; Department of Paediatrics and Child Health, College of Health Sciences, University of Zimbabwe, Harare, Zimbabwe.
  • Majahasi F; Bugando Medical Centre, Mwanza, Tanzania.
  • Ogundoyin O; Department of Surgery, College of Medicine, University College Hospital, University of Ibadan, Ibadan, Nigeria.
  • Renner L; Department of Child Health, University of Ghana School of Medicine and Dentistry, Accra, Ghana.
  • Petricca K; Unit for Policy and Economic Research in Childhood Cancer, The Hospital for Sick Children, Toronto, Ontario, Canada.
  • Denburg AE; Unit for Policy and Economic Research in Childhood Cancer, The Hospital for Sick Children, Toronto, Ontario, Canada.
  • Horton SE; Department of Paediatrics, Faculty of Medicine, University of Toronto, Toronto, Ontario, Canada.
  • Gupta S; Unit for Policy and Economic Research in Childhood Cancer, The Hospital for Sick Children, Toronto, Ontario, Canada.
Cancer ; 127(5): 787-793, 2021 03 01.
Article in En | MEDLINE | ID: mdl-33108002
ABSTRACT

BACKGROUND:

The treatment of childhood cancer often is assumed to be costly in African settings, thereby limiting advocacy and policy efforts. The authors determined the cost and cost-effectiveness of maintaining childhood cancer centers across 4 hospitals throughout sub-Saharan Africa.

METHODS:

Within hospitals representing 4 countries (Kenya, Nigeria, Tanzania, and Zimbabwe), cost was determined either retrospectively or prospectively for all inputs related to operating a pediatric cancer unit (eg, laboratory costs, medications, and salaries). Cost-effectiveness was calculated based on the annual number of newly diagnosed patients, survival rates, and life expectancy.

RESULTS:

Cost per new diagnosis ranged from $2400 to $31,000, attributable to variances with regard to center size, case mix, drug prices, admission practices, and the treatment abandonment rate, which also affected survival. The most expensive cost input was found to be associated with medication in Kenya, and medical personnel in the other 3 centers. The cost per disability-adjusted life-year averted ranged from 0.3 to 3.6 times the per capita gross national income. Childhood cancer treatment therefore was considered to be very cost-effective by World Health Organization standards in 2 countries and cost-effective in 1 additional country. In all centers, abandonment of treatment was common; modeling exercises suggested that public funding of treatment, additional psychosocial personnel, and modifications of inpatient policies would increase survival rates while maintaining or even improving cost-effectiveness.

CONCLUSIONS:

Across various African countries, childhood cancer treatment units represent cost-effective interventions. Cost-effectiveness can be increased through the control of drug prices, appropriate policy environments, and decreasing the rate of treatment abandonment. These results will inform national childhood cancer strategies across Africa.
Subject(s)
Key words

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Neoplasms Type of study: Guideline / Health_economic_evaluation Aspects: Patient_preference Limits: Humans Country/Region as subject: Africa Language: En Journal: Cancer Year: 2021 Document type: Article Affiliation country: Kenya

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Neoplasms Type of study: Guideline / Health_economic_evaluation Aspects: Patient_preference Limits: Humans Country/Region as subject: Africa Language: En Journal: Cancer Year: 2021 Document type: Article Affiliation country: Kenya